胸腹主动脉瘤腔内修复术的手术量而非近肾动脉修复量与小动脉瘤修复术后结局相关
研究基于血管质量倡议2014至2021年5335例胸腹主动脉瘤腔内修复术,按术者年均手术量四分位分组,发现最高手术量组围术期死亡、中风、永久性脊髓缺血、透析等复合终点更低,但近肾动脉腔内修复量校正后与任何术后结局无关,中期死亡风险在最高两个四分位组更低。
要点
- 术者胸腹主动脉瘤腔内修复量越高,围术期死亡、中风、永久性脊髓缺血和透析复合终点发生率越低。
- 校正胸腹主动脉瘤手术量后,术者近肾动脉腔内修复量不与任何术后结局相关,且两者无显著交互作用。
- 最高两个四分位组的中期死亡风险更低,风险比0.77(95%CI 0.61-0.97;P=0.024)。
核心结论
- 术者胸腹主动脉瘤腔内修复经验对围术期结局和以患者为中心的永久性结局呈现强烈的手术量-结局效应。
- 在更广泛动脉瘤中的经验并未直接转化为胸腹主动脉瘤修复的经验。
- 需要进一步研究评估商用移植物可及性和修复类型对这些发现的贡献。
研究设计与样本
- 研究纳入血管质量倡议2014至2021年所有胸腹主动脉瘤腔内修复术(Crawford 1-3型)。
- 根据术者年均胸腹主动脉瘤腔内修复量和近肾动脉腔内修复量将术者分为四分位。
- 共识别607名术者的5335例修复,其中400名术者年均胸腹主动脉瘤腔内修复量合计2629例。
- 采用混合效应逻辑回归,按中心和术者聚类。
主要发现
- 第1四分位为每年少于2例修复,第4四分位为每年超过12例修复。
- 较高四分位组的修复针对更大动脉瘤,更常采用分期修复、脊髓引流和医师改良覆膜支架,而低手术量术者最常采用平行支架技术。
- 较高手术量术者总体手术时间、透视时间和总造影剂用量更少,技术成功率随手术量增加而提高。
- 校正分析中,最高手术量四分位组较低手术量四分位组的围术期死亡、胸腹主动脉瘤危及生命事件、中风、急性肾损伤和主要不良心脏事件发生率均更低。
- 校正胸腹主动脉瘤手术量后,术者近肾动脉腔内修复量与任何术后结局无关,且近肾动脉与胸腹主动脉瘤手术量间无显著交互作用。
关键数值与推荐
- 主要结局为胸腹主动脉瘤危及生命事件,即围术期死亡、中风、永久性脊髓缺血和透析的复合终点。
- 最高两个四分位组的中期死亡风险最低,风险比0.77(95%CI 0.61-0.97;P=0.024)。
- 第1四分位:每年少于2例修复;第4四分位:每年超过12例修复。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需要进一步研究评估商用移植物可及性和修复类型对这些发现的贡献。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Endovascular thoracoabdominal aortic aneurysm (eTAAA) repair remains one of the more technically challenging aspect of vascular surgery, with significant risk of mortality, spinal cord ischemia, and end organ damage. Although fenestrated devices are available for juxtarenal aneurysms, there are no commercially available eTAAA devices on the United States market currently. We therefore studied how the volume of juxtarenal repairs would translate to outcomes of these more complicated aneurysms. METHODS: We studied all eTAAA repairs (Crawford type 1-3) in the Vascular Quality Initiative from 2014 to 2021 and categorized surgeons into quartiles based on their average annual eTAAA volume and endovascular juxtarenal volume. Our primary outcome was thoracoabdominal life altering events (composite of perioperative death, stroke, permanent spinal cord ischemia, and dialysis). We employed mixed effects logistic regression clustering by center and surgeon. RESULTS: We identified 5335 repairs from 607 surgeons, with annual average eTAAA volumes of 2629 from 400 surgeons. Quartile 1 involved less than two repairs and quartile 4 involved >12 repairs per year. Repairs at higher quartiles were for larger aneurysms, more commonly employed staged repairs, utilized spinal drains, and more frequently utilized physician-modified endografts, whereas low-volume surgeons most commonly employed parallel grafting. Higher volume surgeons had overall shorter procedural times, fluoroscopy time, and less total contrast. Technical success similarly increased as procedure volume increased. In adjusted analyses, rates of perioperative death, thoracoabdominal life altering events, stroke, acute kidney injury, and major adverse cardiac events were all lower in the highest volume quartile compared with the lowest. However, after accounting for eTAAA volume, surgeon volume of endovascular juxtarenal repairs was not associated with any postoperative outcome, and there was no significant interaction between juxtarenal and eTAAA volume. Medium-term mortality was lowest in patients treated in the top two quartiles of volume (hazard ratio, 0.77; 95% confidence interval, 0.61-0.97; P = .024). CONCLUSIONS: Surgeon eTAAA experience shows a strong volume-outcome effect on outcomes in the immediate post operative period and in permanent patient-centered outcomes. However, experience in less extensive aneurysms did not directly translate to thoracoabdominal aneurysms. Further study is needed to evaluate the role that commercial graft availability and repair type contributes to these findings.
引用
- Zenilman A, Dansey KD, Zettervall SL, et al. Surgeon volumes of endovascular thoracoabdominal aneurysm repairs, but not juxtarenal repairs, are associated with outcomes following endovascular repair of thoracoabdominal aneurysms. J Vasc Surg. 2025. PMID: 39914758. doi:10.1016/j.jvs.2025.01.209
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。